Sexual dysfunction in Postmenopausal Women.
Conditions
Interventions
Intervention group: This group includes postmenopausal women with sexual dysfunction. Hypnotherapy will be conducted by a trained researcher who has completed training at the Iranian Scientific Associ
Sponsors
Mazandaran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
45 Years to 55 Years
Inclusion criteria
Inclusion criteria: Postmenopausal women with amenorrhea for 12 months or longer who are married. Aged between 45 and 55 years. Scoring below 26.5 on the Female Sexual Function Index (FSFI), indicating sexual dysfunction. Willing to participate in the study and able to provide written informed consent. Having stable mental health and no history of severe psychiatric disorders (such as uncontrolled depression, schizophrenia, or bipolar disorder). Not receiving hormone replacement therapy (HRT) that could affect sexual function. No history of severe chronic diseases such as uncontrolled diabetes, cardiovascular disease, thyroid disorders, multiple sclerosis (MS), etc. Having moderate to high hypnotizability according to the Stanford Hypnotic Susceptibility Scale. Having access to the internet and the ability to use mobile devices and online tools. Not currently using complementary therapies such as cognitive-behavioral therapy (CBT), yoga, meditation, or similar interventions.
Exclusion criteria
Exclusion criteria: A history of recent gynecological or obstetric surgeries that may affect sexual function. Absence from more than two sessions during the study. Individuals with severe levels of stress and anxiety as assessed by the DASS-21 questionnaire. Current use or discontinuation within the past three months of any medications known to negatively affect sexual function, such as antidepressants, antipsychotics, antiepileptics, anticancer drugs, or newly identified drugs with adverse effects on sexual function. Unwillingness to continue participation in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sexual dysfunction. Timepoint: Before the intervention, immediately after the intervention, and three months after the intervention. Method of measurement: Female Sexual Function Index (FSFI). | — |
Secondary
| Measure | Time frame |
|---|---|
| Consent to intervention. Timepoint: 3 months after the intervention. Method of measurement: Client Satisfaction Questionnaire-8.;Adherence to treatment. Timepoint: 3 months after the intervention. Method of measurement: The mean number of hypnotherapy sessions attended by women in the intervention group, the number of participants who completed the at-home assignments, and the number of participants who fully completed the questionnaires. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactmonireh babouyeh darabi
Mazandaran University of Medical Sciences
Outcome results
None listed